Cholera Vaccines Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
MARKET OVERVIEW
Cholera is a kind of infectious disease caused by the Vibrio cholerae bacteria. It's linked to severe diarrhoea, and it needs to be treated right away because if the disease isn't treated, then it can be fatal and life-threatening. Cholera is anticipated to be a global threat to public health, particularly in underdeveloped areas. Thus, cholera vaccine is essential to control cholera and its infection. There are mainly two type of cholera vaccine available in the market one in inactive vaccine and another in a live vaccine.
MARKET SCOPE
The "Global Cholera Vaccines Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the cholera vaccines market with detailed market segmentation by product and end user. The report provides key statistics on the market status of the leading cholera vaccines market players and offers key trends and opportunities in the market.MARKET SEGMENTATION
MARKET DYNAMICS
Drivers:
Restraints:
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The cholera vaccines market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the cholera vaccines market in these regions.
IMPACT OF COVID-19 ON CHOLERA VACCINES MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
By Product
By End User
MARKET PLAYERS
The report covers key developments in the cholera vaccines market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from cholera vaccines market are anticipated to lucrative growth opportunities in the future with the rising demand for cholera vaccines in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the cholera vaccines market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
Valneva SE
Sanofi
Astellas Pharma, Inc
Intervet Inc
GlaxoSmithKline plc
Pfizer, Inc
Takeda Pharmaceutical Co., Ltd
Emergent BioSolutions Inc.
Eubiologics Co., Ltd
Johnson and Johnson
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Cholera is a kind of infectious disease caused by the Vibrio cholerae bacteria. It's linked to severe diarrhoea, and it needs to be treated right away because if the disease isn't treated, then it can be fatal and life-threatening. Cholera is anticipated to be a global threat to public health, particularly in underdeveloped areas. Thus, cholera vaccine is essential to control cholera and its infection. There are mainly two type of cholera vaccine available in the market one in inactive vaccine and another in a live vaccine.
MARKET SCOPE
The "Global Cholera Vaccines Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the cholera vaccines market with detailed market segmentation by product and end user. The report provides key statistics on the market status of the leading cholera vaccines market players and offers key trends and opportunities in the market.MARKET SEGMENTATION
- Based on product the market is segmented as, Dukoral, Shanchol, Vaxchora, Euvichol and Others.
- Based on end user the market is segmented as, Hospitals and Clinics, Research and Academic Laboratories and Others.
MARKET DYNAMICS
Drivers:
- Increasing prevalence of cholera and other chronic diseases.
- Lack of proper sanitation, unhealthy eating, consumption of contaminated water and food.
- Growing awareness about cholera management and vaccination against the disease.
- R&D activities to develop novel approches in cholera vaccines.
- Rising government emphasis of immunization programs.
Restraints:
- However, high time associated with development of vaccines, and presence of stringent regulatory approvals are likelt to restrain market growth during the forecast period.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The cholera vaccines market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the cholera vaccines market in these regions.
IMPACT OF COVID-19 ON CHOLERA VACCINES MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
Cholera Vaccines Market Report Analysis
Cholera Vaccines Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX Million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Valneva SE
- Sanofi
- Astellas Pharma Inc
- Intervet Inc
- GlaxoSmithKline plc
- Pfizer Inc
- Takeda Pharmaceutical Co Ltd
- Emergent BioSolutions Inc
- Eubiologics Co Ltd
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
By Product
- Dukoral
- Shanchol
- Vaxchora
- Euvichol
By End User
- Hospitals and Clinics
- Research and Academic Laboratories
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
The report covers key developments in the cholera vaccines market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from cholera vaccines market are anticipated to lucrative growth opportunities in the future with the rising demand for cholera vaccines in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the cholera vaccines market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Cholera Vaccines Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ XX Million |
| Market Size by 2031 | US$ XX Million |
| Global CAGR (2023 - 2031) | XX% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
|
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
1. Valneva SE
2. Sanofi
3. Astellas Pharma, Inc
4. Intervet Inc
5. GlaxoSmithKline plc
6. Pfizer, Inc
7. Takeda Pharmaceutical Co., Ltd
8. Emergent BioSolutions Inc.
9. Eubiologics Co., Ltd
10. Johnson and Johnson
1. Valneva SE
2. Sanofi
3. Astellas Pharma, Inc
4. Intervet Inc
5. GlaxoSmithKline plc
6. Pfizer, Inc
7. Takeda Pharmaceutical Co., Ltd
8. Emergent BioSolutions Inc.
9. Eubiologics Co., Ltd
10. Johnson and Johnson
Get Free Sample For